X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

PacBio Service Provider DNA Link Sees Soaring Global Demand for SMRT Sequencing

Thursday, January 23, 2014

Since its founding in 2000, the service provider team at Korea-based DNA Link has sought to differentiate itself from other facilities by being an early adopter of new technologies. The company started during the height of the Human Genome Project and initially offered genotyping assays such as SNaPshot® and TaqMan®. DNA Link later adopted microarrays, and when the next-generation sequencing (NGS) wave hit, the scientists quickly embraced the technology.

DNA Link scientists purchased their PacBio® system virtually as soon as it was commercially available. Today, customer demand for Single Molecule, Real-Time (SMRT®) Sequencing is soaring — making DNA Link’s expertise in running the platform a prime asset. Most projects run on the PacBio system focus on de novo sequencing, but there is growing interest in SNP detection, haplotype phasing, and characterizing repeat regions, particularly in plant and animal genomes.

DNA Link serves several hundred scientists in its home country, which is currently its largest market, but interest from abroad is rising. This month, the company will start operations at its first US branch, located in San Diego, to help build a global presence for the rapidly growing team.

One of the qualities that differentiates the service team is its interaction with customers. Along with the company’s sales team, led by Kevin Koo, DNA Link scientists frequently visit the institutions where their customers are based and encourage in-person consultations at the start of each project. “We do that more than 10 times per week,” Koo says. While it is not possible to extend that model to customers abroad, genomic services leader Gun Eui Lee and his team make sure to attend to those clients with conference calls and emails. This attention to customer service helps to ensure expectations are understood and their scientific recommendations are communicated at the start of a new project. “Their success is our success,” says Koo, “so we want to give them the right direction.”

Other attributes that set DNA Link apart are its competitive pricing and veteran staff of scientists and bioinformaticians. “We have very experienced senior staff,” Koo says, “and they provide the consistent, high-quality data that’s our strong point.”

Much of that data rolls off the PacBio pipeline that DNA Link first established in 2011. “We saw great potential in PacBio sequencing because of the unique long reads,” Lee says. From 2012 to 2013, Lee’s lab more than tripled the number of SMRT Cells used for service projects, reflecting customer demands. “That increase is really amazing,” he says. Demand for PacBio sequencing has been robust within Korea and abroad — so much so that DNA Link is now running more SMRT Cells than flow cells or chips for any of its other sequencing platforms.

Scientific interest for the PacBio service centers primarily on de novo sequencing, Lee says. His sequencing team has used SMRT Sequencing on a number of different organisms, including plant, human, animal, and bacterial genomes. Plant genomes in particular have been of interest, he says, because of their challenging repeat sequences. Short-read assemblies for these large, complex genomes have provided limited information — “but by adding these PacBio long reads, we’ve found that a lot of those repetitive regions were fixed,” Lee adds.

For more on DNA Link, read the full profile or visit their website.

Subscribe for blog updates:

Archives